AMEND CENTERPOINT MEDICAL CENTER — History
CCN 260095 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$379M
Latest Revenue (FY2022)
+6.8%
Revenue CAGR (3yr)
19.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $332M | $354M | $379M | +7.0% | +6.8% |
| Operating Expenses | $263M | $290M | $306M | +5.7% | +7.8% |
| Operating Margin | 20.8% | 18.2% | 19.2% | +5.6% | -3.8% |
| Net Income | $69M | $64M | $73M | +13.0% | +2.7% |
| Licensed Beds | 265 | 265 | 265 | +0.0% | +0.0% |
| Total Patient Days | 62,112 | 67,443 | 69,960 | +3.7% | +6.1% |
| Medicare Day % | 26% | 23% | 23% | -3.4% | -7.4% |
| Medicaid Day % | 11% | 13% | 11% | -13.2% | +0.0% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.1% ($332M → $379M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.8%
This Hospital
+7.6%
State Avg
Latest Margin
19.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $402M | 18.4% |
| FY2024 (proj) | $425M | 17.7% |
| FY2025 (proj) | $449M | 16.9% |